Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
XB-PHENO-25913
Cervino AS et al. (2023)
|
Xla WT + ssbp2 MO
NF26 (in situ hybridization)
|
|
|
|
Fig S5. e j o p
Cervino AS et al. (2023)
|
Xla WT + ssbp2 MO
NF32 (in situ hybridization)
|
|
|
|
Fig. 3 BC
Durant-Vesga J et al. (2023)
|
Xla Wt + meis3 MO
NF18-19 (in situ hybridization)
|
|
|
|
Fig. 7
Durant-Vesga J et al. (2023)
|
Xla Wt + Tg(Xtr.pax8:GFP)del_CNS1/2
NF18-19 (in situ hybridization)
|
|
|
|
XB-PHENO-26031
Buisson I et al. (2015)
|
Xla Wt + pax8 MO
NF18 (in situ hybridization)
|
|
|
|
fig.S2.c
Rankin SA et al. (2012)
|
Xtr Wt + osr1 MO + osr2 MO
NF23-24 (in situ hybridization)
|
|
|
|
Fig 4Fii
Vandenberg LN et al. (2011)
|
Xla Wt + atp6v0cdel
NF20 (in situ hybridization)
|
|
|
|
Fig1 B c1r1; c2r1, c2r3; c3r1,c3r3
Colas A et al. (2008)
|
Xla Wt + fgf4
NF18-19 (in situ hybridization)
|
|
|